Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.62 USD | -1.37% | -5.07% | +32.62% |
30/04 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
29/04 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.62% | 55Cr | |
-2.95% | 9.08TCr | |
-1.97% | 3.9TCr | |
-15.47% | 3.18TCr | |
+62.10% | 2.63TCr | |
-22.81% | 1.41TCr | |
-8.82% | 1.29TCr | |
-11.77% | 1.16TCr | |
-45.97% | 1.09TCr | |
+2.85% | 888.89Cr |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Transcript : Avid Bioservices, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-09-2021 02